Montelukast Prescribing at ROSEMEAD SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
313
Total Quantity
14.9K
NHS Cost
£672
vs National Avg
-54.3%
ROSEMEAD SURGERY prescribed 313 items of Montelukast over the last 12 months at a cost of £672 to the NHS. This is 54.3% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
38
Jun 2026
25
Jun 2026
19
Jun 2026
33
Jun 2026
16
Jun 2026
34
Jun 2026
19
Jun 2026
30
Jun 2026
24
Jun 2026
23
Jun 2026
24
Jun 2026
28
Prescribing Details
| Total Items | 313 |
|---|---|
| Total Quantity | 14,882 |
| Total NHS Cost | £672 |
| Presentations | 4 different forms |
| vs National Average | -54.3% |
Montelukast Prescribing Comparison
| This practice | 313 items |
|---|---|
| National average per practice | 685 items |
| Difference | -54.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.